Brazil clears emergency use of Sinovac, AstraZeneca vaccines, shots begin | The Business Standard
Skip to main content
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Friday
May 09, 2025

Sign In
Subscribe
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
FRIDAY, MAY 09, 2025
Brazil clears emergency use of Sinovac, AstraZeneca vaccines, shots begin

Coronavirus chronicle

Reuters
18 January, 2021, 10:10 am
Last modified: 18 January, 2021, 10:20 am

Related News

  • Brazil police foil bomb plot targeting packed Lady Gaga concert in Rio
  • Woman jailed for 14 years in Brazil after 'lipstick coup'
  • Aid funding disrupts child vaccinations almost as much as pandemic: UN
  • Brazil urging tougher emissions goals ahead of climate summit: sources
  • Trump's White House launches COVID website that criticizes WHO, Fauci and Biden

Brazil clears emergency use of Sinovac, AstraZeneca vaccines, shots begin

Adding to the urgency for vaccinations, a second wave of the outbreak in Brazil is snowballing as the country confronts a new, potentially more contagious variant of the coronavirus that originated in Amazonas state and prompted Britain and Italy to bar entry to Brazilians

Reuters
18 January, 2021, 10:10 am
Last modified: 18 January, 2021, 10:20 am
Health care workers receive a dose of the Sinovac's coronavirus disease (COVID-19) vaccine, after Brazil health regulator Anvisa approved its emergency use at Hospital das Clinicas in Sao Paulo, Brazil January 17, 2021. REUTERS/Amanda Perobelli
Health care workers receive a dose of the Sinovac's coronavirus disease (COVID-19) vaccine, after Brazil health regulator Anvisa approved its emergency use at Hospital das Clinicas in Sao Paulo, Brazil January 17, 2021. REUTERS/Amanda Perobelli

Brazilian health regulator Anvisa on Sunday approved emergency use of Covid-19 vaccines from China's Sinovac Biotech Ltd and Britain's AstraZeneca, clearing the way for immunizations as the pandemic enters a deadly second wave.

Minutes after Anvisa's board voted unanimously to approve both vaccines, Monica Calazans, a 54-year-old nurse in Sao Paulo, became the first person to be inoculated in the country, receiving the Chinese vaccine known as CoronaVac.

President Jair Bolsonaro, a coronavirus skeptic who has refused to take a vaccine himself, is under growing pressure to start inoculations in Brazil, which has lost more than 200,000 to Covid-19 – the worst death toll outside the United States.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

Delays with vaccine shipments and testing results have held up vaccinations in the country, once a global leader in mass immunizations and now a regional laggard after countries such as Chile and Mexico started giving shots last month.

Bolsonaro's government aims to kick off a national immunization program this week but is waiting on shipments of the AstraZeneca vaccine at the center of its plans. That has added to public frustration and offered a political rival the chance to upstage the right-wing president.

Sao Paulo Governor Joao Doria, who oversees the Butantan biomedical center that is partnered with Sinovac in Brazil, said Anvisa's decision was a triumph for science as he gave the go-ahead for the first vaccination in his state.

"A victory for science. A victory for life. A victory for Brazil," Doria tweeted.

Bolsonaro, for whom Doria is a potential center-right rival to his 2022 re-election efforts, has taunted the governor over CoronaVac's disappointing 50% efficacy in Brazilian trials. But the federal Health Ministry has agreed to acquire and distribute the shot for the national immunization drive.

Health Minister Eduardo Pazuello told a news conference that the rush to start vaccinating immediately was an illegal "marketing ploy" and the government would start distributing the vaccines to states on Monday, with the nationwide immunization plan beginning on Wednesday.

Brazil could eventually vaccinate 1 million people a day, he said.

Adding to the urgency for vaccinations, a second wave of the outbreak in Brazil is snowballing as the country confronts a new, potentially more contagious variant of the coronavirus that originated in Amazonas state and prompted Britain and Italy to bar entry to Brazilians.

Butantan, which is set up to fill and finish CoronaVac doses on its production line, plans to supply 46 million doses of the two-dose shot by April, the institute said in a statement. Some 6 million of those are ready to go.

The federally funded Fiocruz institute is still waiting for a delayed shipment of the active ingredient in the AstraZeneca vaccine for finishing on a Rio de Janeiro assembly line.

The Health Ministry has scrambled to line up 2 million ready doses of the AstraZeneca vaccine from India, but officials there have suggested it may take weeks to approve exports. Pazuello said on Sunday he expected the doses from India this week.

Top News

coronavirus in Brazil / Coronavirus Pandemic / Oxford-AstraZeneca / AstraZeneca Covid-19 Vaccine / Oxford-AstraZeneca vaccine / Sinovac Covid-19 Vaccine / Sinovac vaccine / Chinese Sinovac company / Sinovac / Brazil / Covid -19 / Covid / Covid 19 / Vaccine availability / Vaccine distribution

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • NCP-led protesters block Shahbagh demanding ban on AL on 9 May afternoon. Photo: Md Belal Hossain/TBS
    'Road closed until AL is banned': NCP-led Shahbagh blockade grows bigger, Sarjis urges BNP to join
  • Govt says decision on AL ban soon after consultation with political parties
    Govt says decision on AL ban soon after consultation with political parties
  • Hefazat instructs leaders, activists to stay on streets until AL is banned
    Hefazat instructs leaders, activists to stay on streets until AL is banned

MOST VIEWED

  • Bangladesh Investment Development Authority (Bida) Chairman Ashik Chowdhury speaks to media in Chattogram on 8 May 2025. Photo: TBS
    Free Trade Zone to be established on 400 acres in Ctg, AP Moller-Maersk to invest $800m: Bida Chairman
  • Why Atomic Energy Commission resists joining govt's digital payment system
    Why Atomic Energy Commission resists joining govt's digital payment system
  • Infographic: TBS
    Only 6 of Bangladesh's 20 MiG-29 engines now work – Tk380cr repair deal on table
  •  Fragments of what Pakistan says is a drone. May 8, 2025. Photo: Reuters
    Pakistan denies involvement in drone attack in Indian Kashmir, calls it ‘fake’
  • A pink bus stops mid-road in Dhaka’s Shyamoli on Monday, highlighting the challenges facing a reform effort to streamline public transport. Despite involving 2,600 buses and rules against random stops, poor enforcement, inadequate ticket counters, and minimal change have left commuters disillusioned and traffic chaos largely unchanged. Photo:  Syed Zakir Hossain
    Nagar Paribahan, pink bus services hit snag in Dhaka's transport overhaul
  • Chief Adviser Dr Md Yunus meets secretaries at his office on 4 September 2024.Photo: Collected
    Chief adviser to sit with stakeholders on Sunday to address capital market crisis

Related News

  • Brazil police foil bomb plot targeting packed Lady Gaga concert in Rio
  • Woman jailed for 14 years in Brazil after 'lipstick coup'
  • Aid funding disrupts child vaccinations almost as much as pandemic: UN
  • Brazil urging tougher emissions goals ahead of climate summit: sources
  • Trump's White House launches COVID website that criticizes WHO, Fauci and Biden

Features

Kadambari Exclusive by Razbi’s summer shari collection features fabrics like Handloomed Cotton, Andi Cotton, Adi Cotton, Muslin and Pure Silk.

Cooling threads, cultural roots: Sharis for a softer summer

1h | Mode
Photo: Mehedi Hasan

The voice of possibility: How Verbex.ai is giving AI a Bangladeshi accent

1h | Panorama
Graphics: TBS

Why can’t India and Pakistan make peace?

1d | The Big Picture
Graphics: TBS

What will be the fallout of an India-Pakistan nuclear war?

1d | The Big Picture

More Videos from TBS

IPL Suspended Until Further Notice

IPL Suspended Until Further Notice

2h | TBS Stories
Cardinal Prevost elected Pope Leo XIV

Cardinal Prevost elected Pope Leo XIV

6h | TBS Stories
Pakistan’s F-16 jet shot down by India

Pakistan’s F-16 jet shot down by India

6h | TBS World
Why is China confident that the U.S. will lose the trade war?

Why is China confident that the U.S. will lose the trade war?

19h | Others
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net